Sun Pharmaceuticals shares are floating higher to Rs. 452.50 on BSE on Friday and expected to improve company's outlook. It was reached 52 week high at Rs. 479.90 on 10th April, 2020.
Sun Pharma rose by 3.66% to trade at ₹452.70 by 09:22 on Thursday on the NSE exchange, up 3.66% on the day. The volume of Sun Pharma shares traded since the start of the session was ₹2.51M. Sun Pharma has traded in a range of $444.00 to $460.45 on the day.
Later, Sun Pharma has reclaimed the market capitalisation of Rs. 1 trillon after its stocks gained around 38% in last 4 days. Most analysts believe Indian pharma sector’s has been relatively resilient to the Covid-19 disruption, favorable currency tailwinds and stable outlook for India and US business.
Sun Pharmaceutical's share reached highest on April 2015 up to Rs. 1119 after they acquire businesses of Ranbaxy and become 4th largest generic pharmaceutical company of the world. But later, many hurdles came in a way of the company.
Following it, the company was lost their market cap of 1 trillion. But the company regained it after demand of pharmaceuticals surges in USA due to COVID19 pandemic. As it was expected, there are many pharmaceutical companies gained during this pandemic.
